Abstract
Human follicular fluid (hFF), as an extra oocyte microenvironment, is essential to the biological processes of oocyte development. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS), we identified 426 proteins as consistently present in hFF from different participants. According to our gene chip data, the granulosa cells in the follicle locally produce 235 of these proteins. These data suggest that the granulosa cells actively participate in the follicular development by synthesizing important molecules to support the activity of pathways that are essential to oocyte development and genomic preservation. The computational Ingenuity Pathway Analysis (IPA) suggests that the identified proteins have well-established functions in the pathways of steroidogenesis, cell-to-cell signaling and interaction, molecular transport, the antioxidative system, interleukin 1 (IL-1) and IL-6 signaling, liver X receptor/retinoid X receptor (LXR/RXR) activation, and the interconnective insulin-like growth factor and lipid metabolism networks. The hFF peptide composition is likely to serve not only the inflammatory follicular state as has been previously suggested; rather, it is a highly diverse and multifunctional environment with several interconnected pathways. These results provide us with important knowledge related to the environment in which the oocyte develops as well as the molecular basis for controlling the process independently of blood supply.
Similar content being viewed by others
References
Kolialexi A, Mavrou A, Spyrou G, Tsangaris GT. Mass spectrometry-based proteomics in reproductive medicine. Mass Spectrom Rev. 2008;27(6):624–634.
Schweigert FJ, Gericke B, Wolfram W, Kaisers U, Dudenhausen JW. Peptide and protein profiles in serum and follicular fluid of women undergoing IVF. Hum Reprod. 2006;21(11):2960–2968.
Fortune JE. Ovarian follicular growth and development in mammals. Biol Reprod. 1994;50:225–232.
Angelucci S, Ciavardelli D, Di Giuseppe F, et al. Proteome analysis of human follicular fluid. Biochim Biophys Acta. 2006;1764(11):1775–1785.
Hanrieder J, Nyakas A, Naessen T, Bergquist J. Proteomic analysis of human follicular fluid using an alternative bottom-up approach. J Proteome Res. 2008;7(1):443–449.
Richards JS. Hormonal control of gene expression in the ovary. Endocr Rev. 1994;15:725–751.
Tsafriri A, Reich R. Molecular aspects of mammalian ovulation. Exp Clin Endocrinol Diabetes. 1999;107(1):1–11.
Anahory T, Dechaud H, Bennes R, Marin P, Lamb NJ, Laoudj D. Identification of new proteins in follicular fluid of mature human follicles. Electrophoresis. 2002;23(7–8):1197–1202.
Assou S, Anahory T, Pantesco V, et al. The human cumulus-oocyte complex gene-expression profile. Hum Reprod. 2006;21(7):1705–1719.
Von Wald T, Monisova Y, Hacker MR, et al. Age-related variations in follicular apolipoproteins may influence human oocyte maturation and fertility potential. Fertil Steril. 2010;93(7):2354–2361.
Smith LP, Nierstenhoefer M, Yoo SW, Penzias AS, Tobiasch E, Usheva A. The bile acid synthesis pathway is present and functional in the human ovary. PLoS One. 2009;4(10):e7333.
Oyawoye O, Abdel Gadir A, Garner A, Constantinovici N, Perrett C, Hardiman P. Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. Hum Reprod. 2003;18(11):2270–2274.
Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991;286(1–2):152–154.
Oda MN, Bielicki JK, Berger T, Forte TM. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity. Biochemistry. 2001;40(6):1710–1718.
Aleporou-Marinou V, Pappa H, Yalouris P, Patargias T. Purification of apolipoprotein H (beta 2-glycoprotein I)-like protein from human follicular fluid. Comp Biochem Physiol B Biochem Mol Biol. 2001;128(3):537–542.
Estes SJ, Ye B, Qiu W, Cramer D, Hornstein MD, Missmer SA. A proteomic analysis of IVF follicular fluid in women <or=32 years old. Fertil Steril. 2009;92(5):1569–1578.
Trougakos IP, Lourda M, Antonelou MH, et al. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin Cancer Res. 2009;15(1):48–59.
Schwarz M, Spath L, Lux CA, et al. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity. Thromb Haemost. 2008;100(1):110–118.
Song H, Saito K, Fujigaki S, et al. IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells. Cytokine. 1998;10(4):275–280.
Zhou J, Bondy C. Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod. 1993;48(3):467–482.
Giudice LC, van Dessel HJ, Cataldo NA, Chandrasekher YA, Yap OW, Fauser BC. Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome. Prog Growth Factor Res. 1995;6(2–4):397–408.
Wang TH, Chang CL, Wu HM, Chiu YM, Chen CK, Wang HS. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril. 2006;86(5):1392–1401.
Richardson DR. More roles for selenoprotein P: local selenium storage and recycling protein in the brain. Biochem J. 2005;386:e5–e7.
Das S, Chattopadhyay R, Ghosh S, et al. Reactive oxygen species level in follicular fluid—embryo quality marker in IVF?. Hum Reprod. 2006;21(9):2403–2407.
Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol. 2006;18(3):325–332.
Freeman MW, Moore KJ. eLiXiRs for restraining inflammation. Nat Med. 2003;9(2):168–169.
Mohan M, Thirumalapura NR, Malayer J. Bovine cumulus-granulosa cells contain biologically active retinoid receptors that can respond to retinoic acid. Reprod Biol Endocrinol. 2003;1:104.
Drouineaud V, Sagot P, Garrido C, et al. Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists. Mol Hum Reprod. 2007;13(6):373–379.
Malizia BA, Wook YS, Penzias AS, Usheva A. The human ovarian follicular fluid level of interleukin-8 is associated with follicular size and patient age. Fertil Steril. 2010;93(2):537–543.
Gerard N, Caillaud M, Martoriati A, Goudet G, Lalmanach AC. The interleukin-1 system and female reproduction. J Endocrinol. 2004;180(2):203–212.
Caillaud M, Duchamp G, Gerard N. In vivo effect of interleukin-1beta and interleukin-1RA on oocyte cytoplasmic maturation, ovulation, and early embryonic development in the mare. Reprod Biol Endocrinol. 2005;3:26.
Maeda A, Inoue N, Matsuda-Minehata F, Goto Y, Cheng Y, Manabe N. The role of interleukin-6 in the regulation of granulosa cell apoptosis during follicular atresia in pig ovaries. J Reprod Dev. 2007;53(3):481–490.
Kawasaki F, Kawano Y, Kosay Hasan Z, Narahara H, Miyakawa I. The clinical role of interleukin-6 and interleukin-6 soluble receptor in human follicular fluids. Clin Exp Med. 2003;3(1):27–31.
Salmassi A, Lu S, Hedderich J, Oettinghaus C, Jonat W, Mettler L. Interaction of interleukin-6 on human granulosa cell steroid secretion. J Endocrinol. 2001;170(2):471–478.
Salonen EM, Vartio T, Hedman K, Vaheri A. Binding of fibronectin by the acute phase reactant C-reactive protein. J Biol Chem. 1984;259(3):1496–1501.
Silva JM, Price CA. Insulin and IGF-I are necessary for FSH-induced cytochrome P450 aromatase but not cytochrome P450 side-chain cleavage gene expression in oestrogenic bovine granulosa cells in vitro. J Endocrinol. 2002;174(3):499–507.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoo, S.W., Savchev, S., Sergott, L. et al. A Large Network of Interconnected Signaling Pathways in Human Ovarian Follicles is Supported by the Gene Expression Activity of the Granulosa Cells. Reprod. Sci. 18, 476–484 (2011). https://doi.org/10.1177/1933719110388848
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719110388848